National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 17 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• Daclizumab to Treat HIV-Infected PatientsCompletedNCT00080431Phase 1
• Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected PatientsCompletedNCT00080106Phase 2
• Increasing Condom Use in People at Risk for HIV InfectionStatus unknownNCT00080093Not applicable
• Directly Observed Therapy in HIV Infected Adolescent Focus GroupsCompletedNCT00079729
• Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected PeopleCompletedNCT00078442Phase 2
• Anti-HIV Drugs for Ugandan Patients With HIV and TuberculosisCompletedNCT00078247Phase 3
• Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With AsthmaCompletedNCT00078208
• Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal AllergiesCompletedNCT00078195Phase 2
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
• Safety of the EnvPro HIV Vaccine in Healthy VolunteersCompletedNCT00076947Phase 1
• Safety of RG2077 in Patients With Multiple SclerosisCompletedNCT00076934Phase 1
• Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the ArmCompletedNCT00076817Phase 1
• Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsCompletedNCT00076791Phase 1
• The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)CompletedNCT00076518Phase 2
• Leukapheresis for Research on HCV-Coinfected PatientsCompletedNCT00076427
• GW873140 to Treat HIV-1 Infected AdultsCompletedNCT00076284Phase 2
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV VaccinesCompletedNCT00076063Phase 1/2
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEPCompletedNCT00076037Phase 1
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected AdolescentsCompletedNCT00075907Phase 3
• A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide TrialsCompletedNCT00075062
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
• Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIVCompletedNCT00074399Phase 3
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and AdolescentsCompletedNCT00073424
• Immune Function of Infants With HIVCompletedNCT00073229
• Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected AdultsCompletedNCT00073216Phase 1
• Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)WithdrawnNCT00073086
• Experimental Ebola Vaccine TrialCompletedNCT00072605Phase 1
• An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard TherapiesCompletedNCT00072592Phase 1
• Racial Difference in HCV/Host InteractionsCompletedNCT00071916
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected AdultsCompletedNCT00071851Phase 1/2
• An Electronic Pillbox for People With HIVStatus unknownNCT00071500Phase 1
• Growth Hormone to Increase Immune Function in People With HIVCompletedNCT00071240Phase 2
• Immune Response to Influenza Vaccine in HIV-Infected IndividualsCompletedNCT00069914
• Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected PatientsCompletedNCT00069498Phase 1
• Resistance to HIV InfectionStatus unknownNCT00069485
• Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected AdultsCompletedNCT00069030Phase 1
• A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and YouthCompletedNCT00069004
• HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, ChinaWithdrawnNCT00068991Phase 1
• Analysis of Immune Responses to HIV VaccinesCompletedNCT00068978
• VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious DiseasesCompletedNCT00068926
• Human Immune Responses SmallpoxCompletedNCT00068198Phase 1
• Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated LymphomaCompletedNCT00068146
• IVIG - West Nile Encephalitis: Safety and EfficacyCompletedNCT00068055Phase 1/2
• Evaluating Immune Function Tests in People With HIVCompletedNCT00067795
• Antiviral Therapy and HIV in the Female Genital TractCompletedNCT00067106
• Investigating Severe Acute Respiratory Syndrome (SARS)CompletedNCT00066209
• Pyrimethamine to Treat Autoimmune Lymphoproliferative SyndromeCompletedNCT00065390Phase 1
• Dressing Preparations for SmallpoxCompletedNCT00063856Phase 1/2
• Anthrax-rPA: Safety, Tolerability, ImmunogenicityCompletedNCT00063843Phase 1
• Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow TransplantCompletedNCT00063817Phase 1
• Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected MenCompletedNCT00063804Phase 1
• Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney FailureCompletedNCT00062621Phase 1
• Safety of an Oral HIV Vaccine in HIV Uninfected VolunteersStatus unknownNCT00062530Phase 1
• Daily Nevirapine to Prevent Mother to Infant Transmission of HIVCompletedNCT00061321Phase 3
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected PatientsCompletedNCT00061256Phase 2
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected AdultsStatus unknownNCT00061243Phase 1
• Alternative Dosing Strategy for Anti-HIV DrugsCompletedNCT00059384Phase 4
• Male Circumcision and HIV Rates in KenyaCompletedNCT00059371Phase 3
• Zidovudine Levels in HIV Infected Patients Being Treated for HCVCompletedNCT00059358Phase 1/2
• Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected PatientsCompletedNCT00058734Phase 1
• Evaluation of a Diabetes Vaccine in Newly Diagnosed DiabeticsCompletedNCT00057499Phase 1
• Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS PatientsTerminatedNCT00057486Phase 1/2
• Vitamin A Therapy for TuberculosisCompletedNCT00057434Phase 3
• Tuberculosis in HIV Infected Patients in UgandaCompletedNCT00057421Phase 2
• Tuberculosis Prevention for HIV Infected AdultsCompletedNCT00057122Phase 3
• Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIVCompletedNCT00056797Phase 2
• HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV DrugsCompletedNCT00056758Phase 1
• Determining an Effective Site (Groin Versus Arm) for Giving HIV VaccinesCompletedNCT00056745Phase 1
• Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's DiseaseCompletedNCT00056355Phase 1
• Treatment of Hepatitis C in Hemophilic Patients With HIVCompletedNCT00055341Phase 2
• When to Start Anti-HIV Drugs in Patients With Opportunistic InfectionsCompletedNCT00055120Phase 4
• Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected ChildrenCompletedNCT00055107Phase 1/2
• Treatment of Acute HIV Infection to Preserve Immune FunctionCompletedNCT00055094
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected AdultsCompletedNCT00054860Phase 1
• Diagnosing Tuberculosis in HIV Infected Children in PeruCompletedNCT00054769
• Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against SmallpoxCompletedNCT00053742Phase 1
• Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral TransmissionCompletedNCT00053612Phase 2
• Handheld Computers to Improve Adherence to Anti-HIV Drug RegimensCompletedNCT00053443Phase 2
• Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected PeopleCompletedNCT00053430Phase 2
• Immunologic Control of Drug Resistant HIVStatus unknownNCT00053404
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected PatientsCompletedNCT00052182Phase 1
• Development of a New HIV VaccineCompletedNCT00051922Phase 1
• Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive AdultsCompletedNCT00051831Not applicable
• Promoting Adherence to Anti-HIV Drug RegimensCompletedNCT00051805Not applicable
• Computer-Assisted Adherence Program for Patients Taking Anti-HIV DrugsTerminatedNCT00051766Not applicable
• Screening HIV-Infected Patients for Vaccine StudiesCompletedNCT00051519
• Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy AdultsCompletedNCT00051454Phase 1/2
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable
• Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
• Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV DrugsCompletedNCT00050921Not applicable
• Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV DrugsCompletedNCT00050908
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive PatientsCompletedNCT00050895Phase 3
• Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 InfectionCompletedNCT00050856Phase 3
• Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2CompletedNCT00050726Phase 2
• APSV in Vaccinia Naive AdultsCompletedNCT00050518Phase 2
• Expanded Dryvax Dilution Study in Previously Vaccinated AdultsCompletedNCT00050505Phase 2
• Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated RecipientsCompletedNCT00050310
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV InfectionCompletedNCT00050284
• Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral NeuropathyCompletedNCT00050271Not applicable

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas